At Drugtrain, we are committed to maintaining the trust and confidence of our customers and visitors to our website. Here you’ll find information on how we treat data that we collect. We treat your personal data with care and we do not sell, rent or exchange your personal information with any third party for commercial reasons.
Visitors To Our Website
When someone visits www.drugtrain.org.uk we use a third party service, Google Analytics, to collect standard internet log information and details of visitor behaviour patterns. We do this to find out things such as the number of visitors to the various parts of the site. This information is only processed in a way which does not identify anyone. We do not make, and do not allow Google to make any attempt to find out the identities of those visiting our website.
By continuing to use this website you are giving your consent to their use, if you are unhappy with this, you must stop using this website immediately.
As part of the registration process, Drugtrain will request the details of each person who attends our training. These details include full name, job title, organisation they work for and their email address. We will ask each delegate to sign the register upon arrival and to give their consent for us to send them our e-marketing & e-newsletter.
Advice Or Quote Request
When you contact Drugtrain for advice or to request a quote we usually ask you for your full name, job title, the organisation you work for and your contact details (telephone number and e-mail address) so that we can fulfil your request. You have the option to withhold personal information that is not required for the request. We do not collect sensitive information about you except when you specifically knowingly provide it.
Drugtrain will not generally ask you for any personal or business banking details. If we do need these details, we will explain exactly why we need these and how they will be used (usually to process a refund) and stored
The personal information we gather is safely stored on Act! which is a Customer Relationship Management (CRM) software application, and will be used to update people about new products/services provided by Drugtrain. We would usually contact people by sending e-marketing or an e-newsletter. We may also contact individuals to check that our records are right and to check every now and then that they’re happy and satisfied. We will only contact individuals with their consent. In order to maintain the accuracy of our database, you can check, update or remove your personal details by contacting Drugtrain at any time
E-Marketing & E-Newsletter
Drugtrain use a third party provider, Swiftpage, to deliver our e-marketing & e-newsletters. We gather statistics around email opening and clicks using industry standard technologies to help us monitor and improve the email marketing and newsletters we send. For more information, please see the Swiftpage Privacy Notice. You can unsubscribe to general mailings at any time of the day or night by clicking the unsubscribe link at the bottom of any of our emails or by emailing Jenny Christie at Drugtrain.
Drugtrain uses WeTransfer to share electronic resources with our customers. In order for the sharing to take place, we will only input each individual’s email address. For more information, please see the WeTransfer Privacy Notice.
Access To Your Personal Information
You are entitled to access the personal information that we hold. Email your request to Jenny Christie at Drugtrain.
Security Of Your Personal Information
Drugtrain will take reasonable technical and organisational precautions and follow strict security procedures in the storage and disclosure of information which you have trusted us with, to prevent unauthorised access, loss, misuse or alteration of your personal information. We will store all the personal information you provide on our secure (password- and firewall- protected) servers. Any ‘hard-copy’ personal information we hold will be kept in locked cabinets with a clear destroy date.
We keep our privacy notice under regular review. This privacy notice was last updated on 21 May 2018.